Management of relapsed Hodgkin's disease patients with high-dose chemotherapy and marrow stem-cell transplantation

被引：1

作者：

Armitage, JO ^{[1
]}

机构：

[1] Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE 68198 USA

来源：

ANNALS OF ONCOLOGY | 2000年 / 11卷 / 06期

关键词：

D O I：

10.1023/A:1008302104009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

收藏

页码：645 / 646

页数：2

相关论文

共 16 条

[1] Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure:: A case-control study [J].

André, M ;

Henry-Amar, M ;

Pico, JL ;

Brice, P ;

Blaise, D ;

Kuentz, M ;

Coiffier, B ;

Colombat, P ;

Cahn, JY ;

Attal, M ;

Fleury, J ;

Milpied, N ;

Nedellec, G ;

Biron, P ;

Tilly, H ;

Jouet, JP ;

Gisselbrecht, C .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :222-229

[2] High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease [J].

Argiris, A ;

Seropian, S ;

Cooper, DL .

ANNALS OF ONCOLOGY, 2000, 11 (06) :665-672

[3] HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC RESCUE IN HODGKINS-DISEASE - LONG-TERM FOLLOW-UP IN 128 PATIENTS [J].

BIERMAN, PJ ;

BAGIN, RG ;

JAGANNATH, S ;

VOSE, JM ;

SPITZER, G ;

KESSINGER, A ;

DICKE, KA ;

ARMITAGE, JO .

ANNALS OF ONCOLOGY, 1993, 4 (09) :767-773

[4]

Bierman PJ, 1996, ANN ONCOL, V7, P151

[5]

CARELLA AM, 1991, BONE MARROW TRANSPL, V8, P99

[6] PROLONGED DISEASE-FREE SURVIVAL IN HODGKINS-DISEASE WITH MOPP REINDUCTION AFTER 1ST RELAPSE [J].

FISHER, RI ;

DEVITA, VT ;

HUBBARD, SP ;

SIMON, R ;

YOUNG, RC .

ANNALS OF INTERNAL MEDICINE, 1979, 90 (05) :761-763

[7] HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED HODGKINS-DISEASE [J].

JAGANNATH, S ;

DICKE, KA ;

ARMITAGE, JO ;

CABANILLAS, FF ;

HORWITZ, LJ ;

VELLEKOOP, L ;

ZANDER, AR ;

SPITZER, G .

ANNALS OF INTERNAL MEDICINE, 1986, 104 (02) :163-168

[8] Autotransplantation for relapsed or refractory Hodgkin's disease: long-term follow-up and analysis of prognostic factors [J].

Lancet, JE ;

Rapoport, AP ;

Brasacchio, R ;

Eberly, S ;

Raubertas, RF ;

Linder, T ;

Muhs, A ;

Duerst, RE ;

Abboud, CN ;

Packman, CH ;

DiPersio, JF ;

Constine, LS ;

Rowe, JM ;

Liesveld, JL .

BONE MARROW TRANSPLANTATION, 1998, 22 (03) :265-271

[9] Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the autologous blood and marrow transplant registry [J].

Lazarus, HM ;

Rowlings, PA ;

Zhang, MJ ;

Vose, JM ;

Armitage, JO ;

Bierman, PJ ;

Gajewski, JL ;

Gale, RP ;

Keating, A ;

Klein, JP ;

Miller, CB ;

Phillips, GL ;

Reece, DE ;

Sobocinski, KA ;

van Besien, K ;

Horowitz, MM .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) :534-545

[10] DOSE INTENSIFICATION WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED AND RESISTANT HODGKINS-DISEASE - RESULTS OF A BNLI RANDOMIZED TRIAL [J].

LINCH, DC ;

WINFIELD, D ;

GOLDSTONE, AH ;

MOIR, D ;

HANCOCK, B ;

MCMILLAN, A ;

CHOPRA, R ;

MILLIGAN, D ;

HUDSON, GV .

LANCET, 1993, 341 (8852) :1051-1054